Skip to main content
Premium Trial:

Request an Annual Quote

Anne Pontius, Neil Cook, Kathleen Wiltsey

Premium
Anne Pontius has joined Expression Analysis as senior director of quality systems. Pontius will be responsible for regulatory compliance and quality analysis activities in the company's testing facility, EA said.
 
She most recently served as president and principal consultant for Laboratory Compliance Consultants, a national consulting firm specializing in regulatory compliance, financial feasibility, and operational issues for clinical laboratories
 

 
Agilent Technologies last week said it has appointed Neil Cook to be vice president and director of the company’s Molecular Technology Laboratory, and has named him to manage technology and development for the company’s Life Sciences and Chemical Analysis segment.
 
Cook formerly was CSO of PerkinElmer’s Life and Analytical Sciences division, and was a vice president at Amersham Biosciences.
 

 
Sequenom has elected Kathleen Wiltsey to its board of directors. Wiltsey spent 14 years at Amgen and is a director of Lexicon Pharmaceuticals. In 2006 she took a post as executive director for development and launch of the Archon X Prize for Genomics.
 
Wiltsey also is president-elect of the board of the associates of the California Institute of Technology.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.